OAM
GDRX icon

Oxford Asset Management’s GoodRx Holdings GDRX Stock Holding History

Oxford Asset Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,210
Closed -$75.4K – 562
2024
Q4 		$75.4K Buy
+16,210
New +$89.1K 0.03% 408

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

Oxford Asset Management's GDRX Position: Q1 2025 in Review

Oxford Asset Management sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 16,210 shares — an estimated $75.4K sold.

Oxford Asset Management first reported a position in GDRX in Q4 2024 and held it in 1 quarter. The position peaked at $75.4K in Q4 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Oxford Asset Management reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Oxford Asset Management sold 16,210 GoodRx Holdings shares in Q1 2025, an estimated $75.4K.
  • Oxford Asset Management first reported a position in GoodRx Holdings in Q4 2024 and held it in 1 quarter.
  • Oxford Asset Management's GoodRx Holdings position peaked at $75.4K in Q4 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.